N. Anthony Coles - Director at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

N. Anthony Coles - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by N. Anthony Coles for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 46,322 $1.96 M $42.24 Feb 6, 2024 Direct Common Stock
Common Stock 25,928 $1.07 M $41.18 Jul 1, 2024 Direct
Stock Option (Right to Buy) 2,177,417 Jul 1, 2024 Direct Common Stock

Transactions reported by N. Anthony Coles for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership